Managing Migraine: Medication Overuse Headache and Treatment with Eptinezumab

Managing Migraine: Medication Overuse Headache and Treatment with Eptinezumab

Abstract Medication overuse headache (MOH) places both a physical and emotional burden on patients. MOH may occur as a consequence of a negative spiral of events comprising an increasing number of headache days while taking frequent or excessive amounts of medications for acute treatment of headache...

Full description

Bibliographic Details
Main Author:	Nicole Limberg
Format:	Article
Language:	English
Published:	Adis, Springer Healthcare 2023-06-01
Series:	Pain and Therapy
Subjects:	Migraine Eptinezumab Medication overuse headache Australia
Online Access:	https://doi.org/10.1007/s40122-023-00534-w

Similar Items

Efficacy and safety of eptinezumab in patients with chronic migraine and medication-overuse headache: a randomized, double-blind, placebo-controlled study
by: Shengyuan Yu, et al.
Published: (2023-12-01)

Adding eptinezumab to brief patient education to treat chronic migraine and medication-overuse headache: Protocol for RESOLUTION—A phase 4, multinational, randomized, double-blind, placebo-controlled study
by: Rigmor H. Jensen, et al.
Published: (2023-02-01)

Quantity changes in acute headache medication use among patients with chronic migraine treated with eptinezumab: subanalysis of the PROMISE-2 study
by: Robert P. Cowan, et al.
Published: (2022-09-01)

Management of medication overuse (MO) and medication overuse headache (MOH) S1 guideline
by: Hans-Christoph Diener, et al.
Published: (2022-08-01)

Medication Overuse Headaches among Children—The Contribution of Migraine and TTH
by: Jacob Genizi, et al.
Published: (2023-09-01)

The journey from genetic predisposition to medication overuse headache to its acquisition as sequela of chronic migraine
by: Paolo Martelletti
Published: (2018-01-01)

Medication-overuse headache. Retrospective comparison of preventive treatments
by: Abouch V. Krymchantowski, et al.

Prevention of medication overuse and medication overuse headache in patients with migraine: a randomized, controlled, parallel, allocation-blinded, multicenter, prospective trial using a mobile software application
by: Hans-Christoph Diener, et al.
Published: (2022-05-01)

Role of Endo-opioid and Endo-cannabinoid Systems in Migraine and Medication-overuse Headache
by: Gökçen Hatipoğlu, et al.
Published: (2022-12-01)

Association between suicidal risks and medication-overuse headache in chronic migraine: a cross-sectional study
by: Yen-Feng Wang, et al.
Published: (2021-05-01)

OnabotulinumtoxinA: An Effective Tool in the Therapeutic Arsenal for Chronic Migraine With Medication Overuse
by: Edoardo Caronna, et al.
Published: (2018-10-01)

Medication overuse headache: a review of current evidence and management strategies
by: Yabets Tesfaye Kebede, et al.
Published: (2023-08-01)

Internal stigmatization in patients with chronic migraine and medication overuse headache
by: Firdevs Ezgi Uçan Tokuç, et al.
Published: (2024-03-01)

Effectiveness and Safety of Eptinezumab in Episodic and Chronic Migraine Headache in the UAE: A Retrospective Study
by: Yazan Bader, et al.
Published: (2023-07-01)

Efficacy and safety of eptinezumab for migraine: A systematic review and meta-analysis
by: Yi Zhong, et al.
Published: (2023-01-01)

Impulsivity prevalence in migraine patients without and with medication overuse
by: Luana Miranda SANTOS, et al.
Published: (2020-11-01)

Medication-overuse headache—a review of different treatment strategies
by: Abouch Krymchantowski, et al.
Published: (2023-10-01)

Clinical Utility of Leeds Dependence Questionnaire in Medication-Overuse Headache
by: Yen-Feng Wang, et al.
Published: (2023-01-01)

Galcanezumab for the treatment of chronic migraine and medication overuse headache: Real‐world clinical evidence in a severely impaired patient population
by: Simona Guerzoni, et al.
Published: (2023-06-01)

Volumetric abnormalities of thalamic subnuclei in medication-overuse headache
by: Zhiye Chen, et al.
Published: (2017-08-01)

Traumatic Experiences, Stressful Events, and Alexithymia in Chronic Migraine With Medication Overuse
by: Sara Bottiroli, et al.
Published: (2018-05-01)

Shift in diagnostic classification of migraine after initiation of preventive treatment with eptinezumab: post hoc analysis of the PROMISE studies
by: Patricia Pozo-Rosich, et al.
Published: (2022-10-01)

Evaluation and treatment of medication-overuse headache: Russian experts’ guidelines
by: G. R. Tabeeva, et al.
Published: (2022-02-01)

Rapid resolution of migraine symptoms after initiating the preventive treatment eptinezumab during a migraine attack: results from the randomized RELIEF trial
by: Jessica Ailani, et al.
Published: (2022-06-01)

Factors associated with acute medication overuse in people with migraine: results from the 2017 migraine in America symptoms and treatment (MAST) study
by: Todd J. Schwedt, et al.
Published: (2018-05-01)

Monoclonal antibodies for chronic migraine and medication overuse headache: A real-world study
by: Abouch V. Krymchantowski, et al.
Published: (2023-03-01)

Theory of mind in chronic migraine with medication overuse assessed with the MASC
by: Sara Bottiroli, et al.
Published: (2024-03-01)

Cardiovascular outcomes in adults with migraine treated with eptinezumab for migraine prevention: pooled data from four randomized, double-blind, placebo-controlled studies
by: Timothy R. Smith, et al.
Published: (2021-11-01)

Early clinical experience with eptinezumab: results of a retrospective observational study of patient response in the United States
by: Amaal J. Starling, et al.
Published: (2023-04-01)

Safety and tolerability of eptinezumab in patients with migraine: a pooled analysis of 5 clinical trials
by: Timothy R. Smith, et al.
Published: (2021-03-01)

Role of educational programs in management of patients with medication-overuse headache
by: A. E. Shagbazyan, et al.
Published: (2021-06-01)

Optimization of acute medication use following eptinezumab initiation during a migraine attack: post hoc analysis of the RELIEF study
by: Roger Cady, et al.
Published: (2022-07-01)

A Descriptive Review of Medication-Overuse Headache: From Pathophysiology to the Comorbidities
by: Srdjan Ljubisavljevic, et al.
Published: (2023-10-01)

Eptinezumab treatment initiated during a migraine attack is associated with meaningful improvement in patient-reported outcome measures: secondary results from the randomized controlled RELIEF study
by: Peter McAllister, et al.
Published: (2022-02-01)

Distinct Food Triggers for Migraine, Medication Overuse Headache and Irritable Bowel Syndrome
by: Merve Ceren Akgor, et al.
Published: (2023-10-01)

Efficacy of mindfulness added to treatment as usual in patients with chronic migraine and medication overuse headache: a phase-III single-blind randomized-controlled trial (the MIND-CM study)
by: Licia Grazzi, et al.
Published: (2023-07-01)

Eptinezumab for the preventive treatment of episodic and chronic migraine: a narrative review
by: Pablo Irimia, et al.
Published: (2024-03-01)

The burden of medication overuse headache and patterns of switching and discontinuation among triptan users: a systematic literature review
by: Alison M. Deighton, et al.
Published: (2021-11-01)

Theory of Mind in migraine and medication-overuse headache: A cross-sectional study
by: Marina Romozzi, et al.
Published: (2022-08-01)

Eptinezumab Demonstrated Efficacy Regardless of Prior Preventive Migraine Treatment Failure Type: Post Hoc Analyses of the DELIVER Study
by: Patricia Pozo-Rosich, et al.
Published: (2024-01-01)